-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ID9T3wKKAxdbRSJR7edI8my84WmrmLCn4o/ERAnH2eMf9zWyDZqTTTFvG7LM5Elo fw5tmH8Iiw/3PPNXGI3UtA== 0000950148-02-000222.txt : 20020414 0000950148-02-000222.hdr.sgml : 20020414 ACCESSION NUMBER: 0000950148-02-000222 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20020201 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: DIAGNOSTIC PRODUCTS CORP CENTRAL INDEX KEY: 0000702259 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 952802182 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-34645 FILM NUMBER: 02525250 BUSINESS ADDRESS: STREET 1: 5700 W 96TH ST CITY: LOS ANGELES STATE: CA ZIP: 90045 BUSINESS PHONE: 3106458200 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: ZIERING MARILYN CENTRAL INDEX KEY: 0001002106 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 5700 W 96TH STREET STREET 2: C/O DIAGNOSTIC PRODUCTS CORP CITY: LOS ANGELES STATE: CA ZIP: 90045 BUSINESS PHONE: 2137760180 MAIL ADDRESS: STREET 1: 5700 W 96TH STREET STREET 2: C/O DIAGNOSTIC PRODUCTS CORP CITY: LOS ANGELES STATE: CA ZIP: 90045 SC 13G/A 1 v78701asc13ga.htm SCHEDULE 13G/AMENDMENT 17 DIAGNOSTIC PRODUCTS SC 13G/AMENDMENT 17
 

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C 20549

Schedule 13G/A

Under the Securities Exchange Act of 1934
(Amendment No. 17)

DIAGNOSTIC PRODUCTS CORPORATION

(Name of Issuer)

COMMON STOCK, NO PAR VALUE

(Title of Class of Securities)

252450-10-1

(CUSIP Number)

December 31, 2001

(Date of Event which Requires Filing This Statement)

     Check the appropriate box to designate the rule pursuant to which this Schedule is filed.

     [   ] Rule 13d-1(b)

     [   ] Rule 13d-1(c)

     [X] Rule 13d-1(d)

* The remainder of this cover page shall be filed out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Page 1 of 3

 

         
SCHEDULE 13G  
 
CUSIP No. 252450-10-1    
                 
1.   NAME OF REPORTING PERSON

MARILYN ZIERING
2.   CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP.   (a) [   ]
        (b) [   ]
3.   SEC USE ONLY


4.   CITIZENSHIP OR PLACE OF ORGANIZATION

U.S.A.

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH

5. SOLE VOTING POWER:

4,803,689
6. SHARED VOTING POWER:

26,400
7. SOLE DISPOSITIVE POWER:

4,803,689
8. SHARED DISPOSITIVE POWER:

26,400
9.   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

4,830,089
10.

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

[   ]
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9.

17.04%
12. TYPE OF REPORTING PERSON

IN

Page 2 of 3

 

     
Item 1(a)   Name of Issuer: Diagnostic Products Corporation
 
Item 1(b)   Address of Issuer’s Principal Executive Offices:
    5700 West 96th Street
Los Angeles, California 90045
 
Item 2(a)   Name of Person Filing: Marilyn Ziering
 
Item 2(b)   Address of Principal Business Office:
5700 West 96th Street
Los Angeles, CA 90045
 
Item 2(c)   Citizenship: U.S.A.
 
Item 2(d)   Title of Class of Securities: Common Stock
 
Item 2(e)   CUSIP Number: 252450-10-1
 
Item 3   Statement filed Pursuant to Rules 13d-1(b) or 13(d)-2(b) or (c): Not Applicable
 
Item 4(a)   Amount Beneficially Owned: 4,830,089 shares are beneficially owned by Marilyn Ziering, including 26,400 shares which are owned by her mother-in-law, as to which beneficial ownership is disclaimed.
 
Item 4(b)   Percent of Class: 17.04%
 
Item 4(c)   For information regarding the number of shares as to which the reporting person has voting and dispositive power, see Items 5-8 of page 2.
 
Item 5   Ownership of 5% or Less of Class: Not Applicable
 
Item 6   Ownership of More than 5% on Behalf of Another Person: Not Applicable
 
Item 7   Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company: Not Applicable
 
Item 8   Identification and Classification of Members of the Group: Not applicable.
 
Item 9   Notice of Dissolution of Group: Not Applicable
 
Item 10   Certification: Not Applicable

     After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
Dated: January 29, 2002   /s/ Marilyn Ziering
    Marilyn Ziering

Page 3 of 3 -----END PRIVACY-ENHANCED MESSAGE-----